Table 3.
Rate of antibiotic resistance in burn isolates
| Antimicrobial agent (disk content) | Percentage of resistant isolates (number of 47) | Percentage of intermediate isolates (number of 47) | Percentage of sensitive isolates (number of 47) |
|---|---|---|---|
| Imipenem (10 µg) | 82.9% (39) | 12.7% (6) | 4.2% (2) |
| Piperacillin (100 µg) | 97.8% (46) | 0% | 2.1% (1) |
| Aztreonam (30 µg) | 93.6% (44) | 2.1% (1) | 4.2% (2) |
| Trimethoprim/sulfamethoxazole (1.25/23.75 µg) | 95.7% (45) | 0% | 4.2% (2) |
| Ampicillin/sulbactam (10-10 µg) | 8.5% (4) | 0% | 91.4% (43) |
| Tobramycin (10 µg) | 87.2% (41) | 2.1% (1) | 10.6% (5) |
| Cefotaxime (30 µg) | 97.8% (46) | 0% | 2.1% (1) |
| Amoxicillin/clavulanic acid (20-10 µg) | 100% (47) | 0% | 0% |
| Tetracycline (30 µg) | 63.8% (30) | 4.2% (2) | 31.9% (15) |
| Piperacillin/tazobactam (100-10 µg) | 63.8% (30) | 31.9% (15) | 4.2% (2) |
| Amikacin (30 µg) | 91.4% (43) | 6.3% (3) | 2.1% (1) |
| Ciprofloxacin (5 µg) | 95.7% (45) | 2.1% (1) | 2.1% (1) |
| Ceftazidime (30 µg) | 97.8% (46) | 0% | 2.1% (1) |
| Gentamicin (10 µg) | 95.7% (45) | 2.1% (1) | 2.1% (1) |
| Cefepime (30 µg) | 93.6% (44) | 4.2% (2) | 2.1% (1) |